INTRODUCTION
============

Rib fracture is the most common form of chest injury that may result from falls, automobile accidents, or assaults. A simple chest posteroanterior and rib series is usually a sufficient diagnostic tool ([@b8-jer-16-1-108]); however, other methods like computed tomography and ultrasound sonography are occasionally used to verify the diagnosis ([@b10-jer-16-1-108]). The primary treatment goal for rib fracture is pain relief. This is mainly achieved with the use of oral nonsteroidal anti-inflammatory drugs; however, in some cases, opioids or more aggressive methods like intercostal nerve block (ICNB) ([@b9-jer-16-1-108]) and epidural or intravenous patient-controlled analgesia are used. The second goal is to prevent pulmonary complications like atelectasis and pneumonia through effective pain management. Effectively managing pain makes it easier for the patient to breathe deeply and expectorate sputum by coughing. Moreover, rib fractures can be treated via plate fixation when a severely displaced fracture causes a flail or deformed chest or when a rib fracture is accompanied by chronic pain or fracture-induced complications ([@b11-jer-16-1-108]).

The prognosis for rib fracture patients is very good and, in most patients, oral drug administration or conservative treatment relieves pain in about 2--3 weeks and treatment can be withdrawn. Callus formation occurs about 8 weeks following the fracture as shown in the rib series taken during follow-up; however, in some cases, callus formation is delayed or, depending on the degree of displacement and whether fixation has been performed, the rib remains displaced. If the patient is of advanced age ([@b13-jer-16-1-108]), has underlying lung disease, or has a lengthened mechanical ventilation period due to flail chest induced by multiple fractures, pulmonary complications and even death from pneumonia or acute respiratory distress syndrome can occasionally occur ([@b3-jer-16-1-108]).

Aside from the anatomical changes related to rib fractures, the physiologic respiratory changes following rib fracture are also monitored in some studies to predict prognosis ([@b1-jer-16-1-108]; [@b4-jer-16-1-108]). The present study aimed to monitor how lung function changes over time during treatment through a periodic assessment of pulmonary function in rib fracture patients following injury and to analyze the factors that can affect the changes in lung function to explore the significance of lung function as a prognostic marker for rib fracture.

MATERIALS AND METHODS
=====================

We enrolled 60 patients with at least one rib fracture who visited the hospital from August 2015 to January 2018 and retrospectively analyzed their medical records. In this study, a pulmonary function test (PFT) was performed at the first visit after injury and then follow-up tests were performed at 1 month and 2 months postinjury. For the test, we measured the forced vital capacity (FVC), forced expiratory volume in 1 sec (FEV~1~), total lung capacity (TLC), and vital capacity (VC) and monitored the changes in the values of each measure. We also investigated the variables that can influence lung function changes such as age, presence of chronic obstructive pulmonary disease (COPD) (FEV~1~/FVC \<70%), number of fractures, and whether the patient had undergone ICNB. Statistical analysis of each variable was conducted using a paired *t*-test and chi-square test (SPSS 12.0, SPSS Inc., Chicago, IL, USA), with the *P*-value ≤0.05 set as significant.

RESULTS
=======

Of the patients with rib fractures who visited the hospital during the study period, a total of 60 patients had at least one fracture and had completed PFT at the first visit. The patients included 43 males and 17 females, aged 20--84 years (average age, 55.1 years) with 1--11 fractures (average, 3.98 fractures). Rib fixation was performed in two cases and ICNB performed in 32 cases. Eleven patients showed an FEV~1~/FVC ratio less than 70% in the first PFT and were suspected to have COPD ([Table 1](#t1-jer-16-1-108){ref-type="table"}). Of the 60 patients who completed the first PFT, 38 completed the second PFT after 1 month and 27 completed the third PFT after 2 months. The results of the first--third PFT and mean values are provided in [Table 2](#t2-jer-16-1-108){ref-type="table"}.

To investigate the variables that can influence PFT parameters, we explored age (65 years or older), the number of fractures (5 or more), presence of COPD, and history of ICNB. We found that these were not significant variables in the PFT parameter changes. Only the presence of COPD showed statistical significance in FEV~1~ recovery 1-month postinjury (*P*=0.035) and it was not a significant variable in the follow-up PFTs. In the second and third PFTs, VC tended to improve more in non-COPD patients (*P*=0.054) ([Table 3](#t3-jer-16-1-108){ref-type="table"}). Most importantly, we observed a significant change over time as the pulmonary function was periodically assessed. In the PFTs immediately following and one month after injury, statistically significant changes were observed across all parameters. In the PFTs 1 month and 2 months after injury, FVC and FEV~1~ continued to show significant changes, whereas the measures of lung volume including TLC and VC showed no significant changes. In the end, FVC and FEV~1~ significantly improved up to 2-month postinjury while TLC and VC did not significantly improve beyond 1-month postinjury ([Fig. 1](#f1-jer-16-1-108){ref-type="fig"}, [Table 4](#t4-jer-16-1-108){ref-type="table"}).

DISCUSSION
==========

Most rib fractures healed with conservative treatment without any particular complications. Pain relief is subjective and can vary depending on individual differences and the pain management method; however, the course and degree of recovery from a rib fracture can be quantified by objective indices such as periodic radiological diagnostic testing, pulmonary function testing, and oxygen saturation testing ([@b2-jer-16-1-108]). According to [@b1-jer-16-1-108] and [@b7-jer-16-1-108], VC is a prognostic marker in older rib fracture patients that shows pulmonary complications that may lead to the need for a long-term care facility after hospital discharge. Moreover, [@b2-jer-16-1-108] reported that the oxygen saturation level can be used as a novel prognostic marker. In the present study, we found no statistically significant improvement in lung function based on age, number of fractures, and ICNB. However, in the case of suspected COPD, it was shown to be a significant variable for FEV~1~ and VC recovery. Aside from using these physiological indices, a previous study attempted to measure lung function recovery by measuring lung volume via the application of a rendering technique to chest CTs ([@b5-jer-16-1-108]).

In a study on lung function recovery based on periodic testing of pulmonary function, [@b6-jer-16-1-108] conducted a 1-year follow-up of patients who underwent rib fixation and reported that FVC and FEV~1~ improved significantly at 6- and 12-month postoperation. In a prospective study on changes in PFT between conservatively treated and surgically treated groups, [@b14-jer-16-1-108] reported that FVC improved continuously over 1 year in the surgically treated group. In the present study, we also confirmed a continued improvement in FVC and FEV~1~ over the 2 months of follow-up. However, [@b12-jer-16-1-108] reported that the changes in FVC and FEV~1~ monitored based on the treatment outcome of rib fixation is statistically insignificant.

The present study was based on a short-term follow-up of the pulmonary function in rib fracture patients who underwent conservative treatment. The follow-up revealed continued FVC and FEV~1~ improvement through 2 months postinjury and lung volume improvement (TLC and VC) through 1-month postinjury. Such findings can be explained by the fact that recovery from decreased lung compliance caused by chest pain improves over the course of treatment and is reflected in the lung capacity measures (FVC, FEV~1~) and lung volume.

Since this is a retrospective study, limitations include selection bias, small sample size, failure to verify the occurrence of pulmonary complications, and the significant shortage of rib fixation cases. Therefore, we believe that the results of this study should be verified by large-scale randomized controlled trials.

In conclusion, this study can be used as evidence for predicting the course of and explaining the recovery process of rib fractures to patients during follow-up.
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###### 

Demographics of patients

  Variable                  Value
  ------------------------- ---------------
  Age (yr)                  55.1 (26--84)
                            
  Sex                       
   Male                     43
   Female                   17
                            
  With COPD                 
   Yes                      11
   No                       49
                            
  No. of fractures          3.98 (1--11)
                            
  Intercostal nerve block   
   Yes                      32
   No                       28
                            
  Rib fixation              2

Values are presented as median (range) or number.

COPD, chronic obstructive pulmonary disease.

###### 

Results of serial pulmonary function tests (PFTs)

  Variable         1st PFT (n=60)         2nd PFT (n=38)         3rd PFT (n=27)
  ---------------- ---------------------- ---------------------- ----------------------
  FVC (%pred)      1.06--4.92 (32--104)   1.15--5.11 (56--115)   1.56--5.23 (70--113)
  FEV~1~ (%pred)   0.71--4.21 (26--113)   0.95--4.18 (55--124)   1.18--4.18 (45--119)
  TLC (%pred)      2.79--7.56 (47--118)   3.66--7.00 (54--115)   1.84--6.66 (74--125)
  VC (%pred)       1.07--4.88 (41--121)   1.31--5.14 (62--119)   2.07--5.40 (68--104)

Values are presented as range.

FVC, forced vital capacity; FEV~1~, forced expiratory volume in 1 sec; TLC, total lung capacity; VC, vital capacity; %pred, percent predicted.

###### 

Significance (*P*-values) of serial changes of PFT according to age, COPD, numbers of fracture, and ICNB

  Variable          0 vs. 1 Month   1 Month vs. 2 months   0 vs. 2 Months
  ----------------- --------------- ---------------------- ----------------
  Age                                                      
   FVC (%pred)      0.532           0.316                  0.509
   FEV~1~ (%pred)   0.139           0.137                  0.495
   TLC (%pred)      0.313           0.845                  0.308
   VC (%pred)       0.091           0.237                  0.330
                                                           
  COPD                                                     
   FVC (%pred)      0.302           0.364                  0.256
   FEV~1~ (%pred)   0.035           0.097                  0.312
   TLC (%pred)      0.515           0.751                  0.404
   VC (%pred)       0.172           0.054                  0.435
                                                           
  ICNB                                                     
   FVC (%pred)      0.312           0.410                  0.345
   FEV~1~ (%pred)   0.467           0.659                  0.477
   TLC (%pred)      0.527           0.331                  0.425
   VC (%pred)       0.650           0.336                  0.204
                                                           
  Numbers                                                  
   FVC (%pred)      0.333           0.567                  0.210
   FEV~1~ (%pred)   0.448           0.37                   0.261
   TLC (%pred)      0.458           0.498                  0.428
   VC (%pred)       0.345           0.097                  0.442

PFT, pulmonary function test; COPD, chronic obstructive pulmonary disease; ICNB, intercostal nerve block; FVC, forced vital capacity; FEV~1~, forced expiratory volume in 1 sec; TLC, total lung capacity; VC, vital capacity; %pred, percent predicted.

###### 

Significance (*P*-values) of serial changes in PFT

  Variable         0 vs. 1 Month   1 Month vs. 2 Months   0 vs. 2 Months
  ---------------- --------------- ---------------------- ----------------
  FVC (%pred)      0.000           0.005                  0.000
  FEV~1~ (%pred)   0.000           0.002                  0.000
  TLC (%pred)      0.000           0.449                  0.002
  VC (%pred)       0.000           0.216                  0.000

PFT, pulmonary function test; FVC, forced vital capacity; FEV~1~, forced expiratory volume in one second; TLC, total lung capacity; VC, vital capacity; %pred, percent predicted.
